Probabilistic graphical models relate immune status with response to neoadjuvant chemotherapy in breast cancer
Probabilistic graphical models relate immune status with response to neoadjuvant chemotherapy in breast cancer |
https://doi.org/10.18632/oncotarget.25496
Andrea Zapater-Moros,
Angelo Gámez-Pozo,
Guillermo Prado-Vázquez,
Lucía Trilla-Fuertes,
Jorge M. Arevalillo,
Mariana Díaz-Almirón,
Hilario Navarro,
Paloma Maín,
Jaime Feliú,
Pilar Zamora,
Enrique Espinosa,
and Juan Ángel Fresno Vara
|
27586-27594 |
Malignant transformation of uterine leiomyoma to myxoid leiomyosarcoma after morcellation associated with ALK rearrangement and loss of 14q
Malignant transformation of uterine leiomyoma to myxoid leiomyosarcoma after morcellation associated with ALK rearrangement and loss of 14q |
https://doi.org/10.18632/oncotarget.25137
Carsten Holzmann,
Christian Saager,
Gunhild Mechtersheimer,
Dirk Koczan,
Burkhard M. Helmke,
and Jörn Bullerdiek
|
27595-27604 |
Comprehensive identification of long noncoding RNAs in colorectal cancer
Comprehensive identification of long noncoding RNAs in colorectal cancer |
https://doi.org/10.18632/oncotarget.25218
Eric James de Bony,
Martin Bizet,
Olivier Van Grembergen,
Bouchra Hassabi,
Emilie Calonne,
Pascale Putmans,
Gianluca Bontempi,
and François Fuks
|
27605-27629 |
Inhibition of GSK3α/β impairs the progression of HNSCC
Inhibition of GSK3α/β impairs the progression of HNSCC |
https://doi.org/10.18632/oncotarget.25250
Lisa Schulz,
Ralph Pries,
Aruna Sree Lanka,
Maren Drenckhan,
and Barbara Wollenberg
|
27630-27644 |
The small molecule STF-62247 induces apoptotic and autophagic cell death in leukemic cells
The small molecule STF-62247 induces apoptotic and autophagic cell death in leukemic cells |
https://doi.org/10.18632/oncotarget.25291
Tomohiro Kozako,
Keisuke Sato,
Yuichiro Uchida,
Naho Kato,
Akiyoshi Aikawa,
Kentaro Ogata,
Hidetoshi Kamimura,
Haruna Uemura,
Makoto Yoshimitsu,
Kenji Ishitsuka,
Yasuki Higaki,
Hiroaki Tanaka,
Shin-Ichiro Honda,
and Shinji Soeda
|
27645-27655 |
Identification of differentially expressed miRNAs and miRNA-targeted genes in bladder cancer
Identification of differentially expressed miRNAs and miRNA-targeted genes in bladder cancer |
https://doi.org/10.18632/oncotarget.24441
Jong-Young Lee,
Seok Joong Yun,
Pildu Jeong,
Xuan-Mei Piao,
Ye-Hwan Kim,
Jihye Kim,
Sathiyamoorthy Subramaniyam,
Young Joon Byun,
Ho Won Kang,
Sung Phil Seo,
Jayoung Kim,
Jung Min Kim,
Eun Sang Yoo,
Isaac Y. Kim,
Sung-Kwon Moon,
Yung Hyun Choi,
and Wun-Jae Kim
|
27656-27666 |
Enhanced proteasomal activity is essential for long term survival and recurrence of innately radiation resistant residual glioblastoma cells
Enhanced proteasomal activity is essential for long term survival and recurrence of innately radiation resistant residual glioblastoma cells |
https://doi.org/10.18632/oncotarget.25351
Jacinth Rajendra,
Keshava K. Datta,
Sheikh Burhan Ud Din Farooqee,
Rahul Thorat,
Kiran Kumar,
Nilesh Gardi,
Ekjot Kaur,
Jyothi Nair,
Sameer Salunkhe,
Ketaki Patkar,
Sanket Desai,
Jayant Sastri Goda,
Aliasgar Moiyadi,
Amit Dutt,
Prasanna Vankatraman,
Harsha Gowda,
and Shilpee Dutt
|
27667-27681 |
New susceptibility loci for cutaneous melanoma risk and progression revealed using a porcine model
New susceptibility loci for cutaneous melanoma risk and progression revealed using a porcine model |
https://doi.org/10.18632/oncotarget.25455
Emmanuelle Bourneuf,
Jordi Estellé,
Amandine Blin,
Françoise Créchet,
Maria del Pilar Schneider,
Hélène Gilbert,
Myriam Brossard,
Amaury Vaysse,
Mark Lathrop,
Silvia Vincent-Naulleau,
and Florence Demenais
|
27682-27697 |
PKM2 under hypoxic environment causes resistance to mTOR inhibitor in human castration resistant prostate cancer
PKM2 under hypoxic environment causes resistance to mTOR inhibitor in human castration resistant prostate cancer |
https://doi.org/10.18632/oncotarget.25498
Yota Yasumizu,
Hiroshi Hongo,
Takeo Kosaka,
Shuji Mikami,
Koshiro Nishimoto,
Eiji Kikuchi,
and Mototsugu Oya
|
27698-27707 |
FOXP3 and miR-155 cooperate to control the invasive potential of human breast cancer cells by down regulating ZEB2 independently of ZEB1
FOXP3 and miR-155 cooperate to control the invasive potential of human breast cancer cells by down regulating ZEB2 independently of ZEB1 |
https://doi.org/10.18632/oncotarget.25523
Cheryl Y. Brown,
Sonia Dayan,
Soon Wei Wong,
Adrian Kaczmarek,
Christopher M. Hope,
Stephen M. Pederson,
Victoria Arnet,
Gregory J. Goodall,
Darryl Russell,
Timothy J. Sadlon,
and Simon C. Barry
|
27708-27727 |
Real-time methylation-specific PCR for the evaluation of methylation status of MGMT gene in glioblastoma
Real-time methylation-specific PCR for the evaluation of methylation status of MGMT gene in glioblastoma |
https://doi.org/10.18632/oncotarget.25543
Masaki Yoshioka,
Tomoo Matsutani,
Ayaka Hara,
Seiichiro Hirono,
Takaki Hiwasa,
Masaki Takiguchi,
and Yasuo Iwadate
|
27728-27735 |
ERα-mediated cell cycle progression is an important requisite for CDK4/6 inhibitor response in HR+ breast cancer
ERα-mediated cell cycle progression is an important requisite for CDK4/6 inhibitor response in HR+ breast cancer |
https://doi.org/10.18632/oncotarget.25552
Karineh Petrossian,
Noriko Kanaya,
Chiao Lo,
Pei-Yin Hsu,
Duc Nguyen,
Lixin Yang,
Lu Yang,
Charles Warden,
Xiwei Wu,
Raju Pillai,
Lauren Bernal,
Chiun-Sheng Huang,
Laura Kruper,
Yuan Yuan,
George Somlo,
Joanne Mortimer,
and Shiuan Chen
|
27736-27751 |
The difference in the survival rate of patients with metastatic renal cell carcinoma in the intermediate-risk group of the Memorial Sloan Kettering Cancer Center criteria
The difference in the survival rate of patients with metastatic renal cell carcinoma in the intermediate-risk group of the Memorial Sloan Kettering Cancer Center criteria |
https://doi.org/10.18632/oncotarget.25554
Satoshi Tamada,
Taro Iguchi,
Sayaka Yasuda,
Minoru Kato,
Takeshi Yamasaki,
and Tatsuya Nakatani
|
27752-27759 |
Targeting the extradomain A of fibronectin allows identification of vascular resistance to antiangiogenic therapy in experimental glioma
Targeting the extradomain A of fibronectin allows identification of vascular resistance to antiangiogenic therapy in experimental glioma |
https://doi.org/10.18632/oncotarget.25570
Güliz Acker,
Sophie Käthe Piper,
Anna Lena Datwyler,
Thomas Broggini,
Irina Kremenetskaia,
Melina Nieminen-Kelhä,
Janet Lips,
Ulrike Harms,
Susanne Mueller,
Gilla Lättig-Tünnemann,
Eveline Trachsel,
Alessandro Palumbo,
Dario Neri,
Jan Klohs,
Matthias Endres,
Peter Vajkoczy,
Christoph Harms,
and Marcus Czabanka
|
27760-27772 |
Activating HER3 mutations in breast cancer
Activating HER3 mutations in breast cancer |
https://doi.org/10.18632/oncotarget.25576
Rosalin Mishra,
Samar Alanazi,
Long Yuan,
Thomas Solomon,
Tarjani M. Thaker,
Natalia Jura,
and Joan T. Garrett
|
27773-27788 |
Docetaxel plus ramucirumab with primary prophylactic pegylated-granulocyte-colony stimulating factor for pretreated non-small cell lung cancer
Docetaxel plus ramucirumab with primary prophylactic pegylated-granulocyte-colony stimulating factor for pretreated non-small cell lung cancer |
https://doi.org/10.18632/oncotarget.25578
Akito Hata,
Daijiro Harada,
Chiyuki Okuda,
Reiko Kaji,
Yoshio Masuda,
Yoshika Takechi,
Toshiyuki Kozuki,
Naoyuki Nogami,
and Nobuyuki Katakami
|
27789-27796 |
A versatile T cell-based assay to assess therapeutic antigen-specific PD-1-targeted approaches
A versatile T cell-based assay to assess therapeutic antigen-specific PD-1-targeted approaches |
https://doi.org/10.18632/oncotarget.25591
Maarten Versteven,
Johan M.J. Van den Bergh,
Katrijn Broos,
Fumihiro Fujiki,
Diana Campillo-Davo,
Hans De Reu,
Soyoko Morimoto,
Quentin Lecocq,
Marleen Keyaerts,
Zwi Berneman,
Haruo Sugiyama,
Viggo F.I. Van Tendeloo,
Karine Breckpot,
and Eva Lion
|
27797-27808 |
The rabbit as an orthologous small animal model for APOBEC3A oncogenesis
The rabbit as an orthologous small animal model for APOBEC3A oncogenesis |
https://doi.org/10.18632/oncotarget.25593
Hélène C. Laude,
Vincent Caval,
Mohamed S. Bouzidi,
Xiongxiong Li,
Florence Jamet,
Michel Henry,
Rodolphe Suspène,
Simon Wain-Hobson,
and Jean-Pierre Vartanian
|
27809-27822 |
A novel oncogenic role for urokinase receptor in leukemia cells: molecular sponge for oncosuppressor microRNAs
A novel oncogenic role for urokinase receptor in leukemia cells: molecular sponge for oncosuppressor microRNAs |
https://doi.org/10.18632/oncotarget.25597
Anna Li Santi,
Anna Gorrasi,
Mariaevelina Alfieri,
Nunzia Montuori,
and Pia Ragno
|
27823-27834 |
Survivin antagonizes chemotherapy-induced cell death of colorectal cancer cells
Survivin antagonizes chemotherapy-induced cell death of colorectal cancer cells |
https://doi.org/10.18632/oncotarget.25600
Anke Rauch,
Annemarie Carlstedt,
Claudia Emmerich,
Al-Hassan M. Mustafa,
Anja Göder,
Shirley K. Knauer,
Michael Linnebacher,
Thorsten Heinzel,
and Oliver H. Krämer
|
27835-27850 |
Feasibility of using stereotactic body radiation therapy for unresectable soft tissue tumors of the trunk
Feasibility of using stereotactic body radiation therapy for unresectable soft tissue tumors of the trunk |
https://doi.org/10.18632/oncotarget.25539
Eun Kyung Paik,
Mi-Sook Kim,
Chul-Koo Cho,
Hyung Jun Yoo,
Won Il Jang,
Young-Seok Seo,
Sung-Ho Jin,
Dae Geun Jeon,
and Dong Han Lee
|
27851-27857 |
Interferon-stimulated gene 20 kDa protein serum levels and clinical outcome of hepatitis B virus-related liver diseases
Interferon-stimulated gene 20 kDa protein serum levels and clinical outcome of hepatitis B virus-related liver diseases |
https://doi.org/10.18632/oncotarget.25559
Hoang Van Tong,
Nghiem Xuan Hoan,
Mai Thanh Binh,
Dao Thanh Quyen,
Christian G. Meyer,
Le Huu Song,
Nguyen Linh Toan,
and Thirumalaisamy P. Velavan
|
27858-27871 |
Dietary patterns and primary liver cancer in Chinese adults: a case-control study
Dietary patterns and primary liver cancer in Chinese adults: a case-control study |
https://doi.org/10.18632/oncotarget.23910
Qiu-Ye Lan,
Gong-Cheng Liao,
Rui-Fen Zhou,
Pei-Yan Chen,
Xiao-Yan Wang,
Min-Shan Chen,
Yu-Ming Chen,
and Hui-Lian Zhu
|
27872-27881 |
Efficacy of azacitidine is independent of molecular and clinical characteristics - an analysis of 128 patients with myelodysplastic syndromes or acute myeloid leukemia and a review of the literature
Efficacy of azacitidine is independent of molecular and clinical characteristics - an analysis of 128 patients with myelodysplastic syndromes or acute myeloid leukemia and a review of the literature |
https://doi.org/10.18632/oncotarget.25328
Andrea Kuendgen,
Catharina Müller-Thomas,
Michael Lauseker,
Torsten Haferlach,
Petra Urbaniak,
Thomas Schroeder,
Carolin Brings,
Michael Wulfert,
Manja Meggendorfer,
Barbara Hildebrandt,
Beate Betz,
Brigitte Royer-Pokora,
Norbert Gattermann,
Rainer Haas,
Ulrich Germing,
and Katharina S. Götze
|
27882-27894 |
Breast cancer recurrence after reconstruction: know thine enemy
Breast cancer recurrence after reconstruction: know thine enemy |
https://doi.org/10.18632/oncotarget.25602
Elizabeth A. Brett,
Matthias M. Aitzetmüller,
Matthias A. Sauter,
Georg M. Huemer,
Hans-Günther Machens,
and Dominik Duscher
|
27895-27906 |
Correction: Dietary cholesterol intake and stroke risk: a meta-analysis
Correction: Dietary cholesterol intake and stroke risk: a meta-analysis |
https://doi.org/10.18632/oncotarget.25644
Pengfei Cheng,
Junxi Pan,
Jinjun Xia,
Wen Huang,
Shunjie Bai,
Xiaofeng Zhu,
Weihua Shao,
Haiyang Wang,
and Peng Xie
|
27907-27907 |
Correction: Endonuclease G promotes mitochondrial genome cleavage and replication
Correction: Endonuclease G promotes mitochondrial genome cleavage and replication |
https://doi.org/10.18632/oncotarget.25645
Rahel Stefanie Wiehe,
Boris Gole,
Laurent Chatre,
Paul Walther,
Enrico Calzia,
Anja Palmer,
J. Christof M. Gebhardt,
Miria Ricchetti,
and Lisa Wiesmüller
|
27908-27908 |